Amarin Corp Plcuk (AMRN) Change in Receivables (2013 - 2026)

Amarin Corp Plcuk (AMRN) posted quarterly Change in Receivables of -$18.8 million for Q1 2026, down 20.82% YoY from -$23.7 million in Q1 2025, and down 3837.32% sequentially from -$477000.0 in Q4 2025.

Amarin Corp Plcuk (AMRN) Change in Receivables (2013 - 2026) Analysis & Trends

Amarin Corp Plcuk has disclosed Change in Receivables across 14 years of filings, most recently posting -$18.8 million for Q1 2026.

  • In Q1 2026, Change in Receivables fell 20.82% year-over-year to -$18.8 million; the TTM figure through Mar 2026 stood at $1.3 million (up 114.52% YoY), while the FY2025 annual figure was $4.6 million, up 140.35% from the prior year.
  • Change in Receivables slipped to -$18.8 million in Q1 2026, from -$477000.0 in the prior quarter.
  • Over the last five years, Change in Receivables for AMRN reached as high as $33.7 million in Q2 2022 and fell as low as -$53.4 million in Q1 2022.
  • The 5-year median for Change in Receivables is -$330000.0 (2023), against an average of -$3.3 million.
  • The widest YoY moves for Change in Receivables: up 175.05% in 2024, down 3248.18% in 2024.
  • A 5-year view of Change in Receivables shows it stood at $7.6 million in 2022, then jumped by 46.67% to $11.2 million in 2023, then slipped by 13.67% to $9.6 million in 2024, then sank by 104.95% to -$477000.0 in 2025, then plunged by 3837.32% to -$18.8 million in 2026.
  • According to Business Quant data, Change in Receivables over the past three periods registered -$18.8 million, -$477000.0, and $8.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn -
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 595.00 Mn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn -87.00 Mn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn -
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn -413.00 Mn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn -134.00 Mn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn -
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Amarin Corp Plcuk 5.17 Bn 5.00 Bn 17.77 Mn -18.78 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -18.78 Mn
Mar 31, 2026 -18.78 Mn
Dec 31, 2025 -477,000.00
Dec 31, 2025 -477,000.00
Sep 30, 2025 8.18 Mn
Sep 30, 2025 8.18 Mn
Jun 30, 2025 12.40 Mn
Jun 30, 2025 12.40 Mn
Mar 31, 2025 -15.55 Mn
Mar 31, 2025 -15.55 Mn
Dec 31, 2024 9.64 Mn
Dec 31, 2024 9.64 Mn
Sep 30, 2024 -11.05 Mn
Sep 30, 2024 -11.05 Mn
Jun 30, 2024 7.89 Mn
Jun 30, 2024 7.89 Mn
Mar 31, 2024 -17.76 Mn
Mar 31, 2024 -17.76 Mn
Dec 31, 2023 11.16 Mn
Dec 31, 2023 11.16 Mn